Form 4 Tracker
Tarsus Pharmaceuticals, Inc.
TARS

51 insider filings · Latest: Sep 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 18, 2026Mar 19 11:04 PMAziz MottiwalaChief Commercial Officer
Sale
4,330$68.71$297.5K65,920(D)

View →

Mar 17, 2026Mar 19 11:04 PMAziz MottiwalaChief Commercial Officer
Sale
4,286$69.42$297.5K70,250(D)

View →

Mar 19, 2026Mar 19 11:04 PMElizabeth Yeu LinChief Medical Officer
Sale
390$67.00$26.1K23,308(D)

View →

Mar 18, 2026Mar 19 11:04 PMElizabeth Yeu LinChief Medical Officer
Sale
379$68.71$26.0K23,698(D)

View →

Mar 17, 2026Mar 19 11:04 PMElizabeth Yeu LinChief Medical Officer
Sale
375$69.42$26.0K24,077(D)

View →

Mar 19, 2026Mar 19 11:03 PMJeffrey S FarrowChief Financial Officer and Chief Strategy Officer
Sale
2,186$67.00$146.5K43,316(D)

View →

Mar 18, 2026Mar 19 11:03 PMJeffrey S FarrowChief Financial Officer and Chief Strategy Officer
Sale
2,133$68.71$146.6K45,502(D)

View →

Mar 17, 2026Mar 19 11:03 PMJeffrey S FarrowChief Financial Officer and Chief Strategy Officer
Sale
2,111$69.42$146.5K47,635(D)

View →

Mar 19, 2026Mar 19 11:03 PMBobak R. AzamianDirector, President/CEO and Board Chair
Sale
11,964$67.00$801.6K33,421(D)

View →

Mar 18, 2026Mar 19 11:03 PMBobak R. AzamianDirector, President/CEO and Board Chair
Sale
11,667$68.71$801.6K45,385(D)

View →

Mar 17, 2026Mar 19 11:03 PMBobak R. AzamianDirector, President/CEO and Board Chair
Sale
10,972$69.42$761.7K57,052(D)

View →

Mar 19, 2026Mar 19 8:43 PMFarrow Jeffrey S
Proposed Sale
2,186$67.00$146.5K—

View →

Mar 19, 2026Mar 19 8:38 PMMottiwala Aziz
Proposed Sale
4,440$67.00$297.5K—

View →

Mar 19, 2026Mar 19 8:30 PMAzamian Bobak R.
Proposed Sale
11,964$67.00$801.6K—

View →

Mar 19, 2026Mar 19 8:24 PMWhitfield Dianne C.
Proposed Sale
4,174$67.00$279.7K—

View →

Mar 19, 2026Mar 19 8:23 PMWahl Bryan
Proposed Sale
4,231$67.00$283.5K—

View →

Mar 19, 2026Mar 19 8:15 PMNeervannan Seshadri
Proposed Sale
4,589$67.00$307.5K—

View →

Mar 19, 2026Mar 19 8:14 PMLin Elizabeth Yeu
Proposed Sale
390$67.00$26.1K—

View →

Mar 18, 2026Mar 18 8:33 PMWhitfield Dianne C.
Proposed Sale
4,071$68.71$279.7K—

View →

Mar 18, 2026Mar 18 8:18 PMWahl Bryan
Proposed Sale
4,125$68.71$283.4K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 15, 2026Sep 17 8:47 PMI E Pyott DavidDirector
Option Exercise
201—605(D)

View →

Sep 15, 2026Sep 17 8:22 PMWendy L YarnoDirector
Option Exercise
302—907(D)

View →

Sep 15, 2026Sep 17 8:22 PMPhd J Link WilliamDirector
Option Exercise
201—605(D)

View →

Jun 25, 2026Jun 29 8:32 PMKatherine GoodrichDirector
Grant/Award
6,254$64.342,417(D)

View →

Jun 25, 2026Jun 29 8:31 PMAndrew D. GoldbergDirector
Grant/Award
6,254$64.342,417(D)

View →

Jun 25, 2026Jun 29 8:31 PMScott W MorrisonDirector
Grant/Award
6,254$64.342,417(D)

View →

Jun 25, 2026Jun 29 8:31 PMBhaskar ChaudhuriDirector
Grant/Award
6,254$64.342,417(D)

View →

Jun 25, 2026Jun 29 8:31 PMWendy L YarnoDirector
Grant/Award
7,463$64.341,209(D)

View →

Jun 25, 2026Jun 29 8:30 PMI E Pyott DavidDirector
Grant/Award
7,060$64.34806(D)

View →

Jun 25, 2026Jun 29 8:30 PMPhd J Link WilliamDirector
Grant/Award
7,060$64.34806(D)

View →

Jun 15, 2026Jun 17 8:17 PMJeffrey S FarrowChief Financial Officer and Chief Strategy Officer
Option Exercise
27,881—27,882(D)

View →

Jun 12, 2026Jun 16 8:06 PMScott W MorrisonDirector
Option Exercise
2,954—0(D)

View →

Jun 12, 2026Jun 16 8:06 PMPhd J Link WilliamDirector
Option Exercise
2,954—0(D)

View →

Jun 12, 2026Jun 16 8:06 PMBhaskar ChaudhuriDirector
Option Exercise
2,954—0(D)

View →

Jun 12, 2026Jun 16 8:05 PMKatherine GoodrichDirector
Option Exercise
2,954—0(D)

View →

Jun 12, 2026Jun 16 8:05 PMWendy L YarnoDirector
Option Exercise
2,954—0(D)

View →

Jun 12, 2026Jun 16 8:05 PMAndrew D. GoldbergDirector
Option Exercise
2,954—0(D)

View →

Apr 24, 2026Apr 28 8:23 PMI E Pyott DavidDirector
Option Exercise
1,383—0(D)

View →

Mar 15, 2026Mar 17 8:40 PMDianne C. WhitfieldChief Human Resources Officer
Option Exercise
23,909—15,067(D)

View →

Mar 15, 2026Mar 17 8:38 PMBryan WahlGeneral Counsel
Option Exercise
24,236—15,067(D)

View →

Page 1 of 2

Next →